An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome
Authors:
- 1 March 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 22 (2) , 1-8
Abstract
Background:: An increase in resistant gram-positive cocci, especially enterococci, requires an epidemiologic re-assay and its results may affect empirical treatments for these infections. Objective:: In this study, we investigated the microbial epidemiology and resistance pattern of enterococcal bacteremia. Methods:: This study was a cross-sectional study that investigates all cases of positive blood cultures with Enterococcus spp. at a tertiary referral colligates hospital in Tehran in 2018. Results:: Enterococcus spp. was isolated from blood cultures of a total of 73 patients. The most patients were male 42 (57.7%). The mean age of the patients was 58.8 (±18.8) years. Hospital-acquired infection was the most type of infection involving enterococcal bacteremia (80.8%) comparing with community-acquired (6.7%) and health care-associated (12.3%). Renal failure and cancer were the most underlying disease in E. faecalis and E. faecium, respectively. Mortality for Vanco-mycin-resistant enterococci (VRE) was approximately two times more than the sensitive ones. Between the dead/alive groups, the following items were different significantly (P.Value<0.05): Vancomycin resistance for enterococcus isolated, immunodeficiency as underlying disease, Mechanical ventilation, hospitalization period, and the empiric regimen. Conclusion:: Increased antibiotic-resistant strains, especially Vancomycin-resistant enterococci (VRE), pose a serious threat to the general public, especially hospitalized patients, and increase mortality. Surveillance of microorganisms and antimi-crobial resistance is a crucial part of an efficient health care system.Keywords
This publication has 21 references indexed in Scilit:
- Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalizationClinical Microbiology and Infection, 2013
- Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium BacteremiaAntimicrobial Agents and Chemotherapy, 2012
- Enterococcal bacteremia is associated with prolonged stay in the medical intensive care unitJournal of Global Infectious Diseases, 2012
- Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital CohortInfection Control & Hospital Epidemiology, 2010
- Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Vancomycin-resistant enterococci bacteremia: Risk factors for mortality and influence of antimicrobial therapy on clinical outcomeJournal of Infection, 2009
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic ResistanceTransplantation and Cellular Therapy, 2009
- Vancomycin Resistance in Gram-Positive CocciClinical Infectious Diseases, 2006
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United StatesInfection Control & Hospital Epidemiology, 2000